CytomX Therapeutics Inc.

NASDAQ: CTMX · Real-Time Price · USD
1.93
0.17 (9.66%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.26%
After-hours: Aug 15, 2025, 07:54 PM EDT

CytomX Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
2.73 -201.06 -1.08 -3.44
PEG Ratio
-0.00 2.02 -0.06 -0.04
PS Ratio
0.63 1.13 1.98 3.99
PB Ratio
-190.73 -2.41 -1.23 3.11
P/FCF Ratio
-1 -2.01 -0.93 -2.3
P/OCF Ratio
-1.01 -2.04 -0.95 -2.33
OCF/S Ratio
-0.62 -0.55 -2.08 -1.71
Debt / Equity Ratio
-20.58 -0.29 -0.21 0.20
Quick Ratio
1.25 1.17 1.55 2.92
Current Ratio
1.25 1.17 1.55 2.92
Asset Turnover
1.15 0.50 0.20 0.20
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-69.89 0.01 1.13 -0.9
Return on Assets
0.26 n/a -0.37 -0.24
Return on Invested Capital
0.62 0.02 -0.88 -0.34
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 0.89 0.92
Net Profit Margin
0.23 -0.01 -1.83 -1.16
Pretax Profit Margin
0.23 0.03 -1.87 -1.2
Operating Profit Margin
0.18 -0.06 -1.91 -1.2
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.19 -0.04 -1.86 -1.63